Tower Research Capital (TRC)’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-588
| Closed | -$3.7K | – | 5906 |
|
|
2024
Q3 | $3.7K | Sell |
588
-5,408
| -90% | -$34K | ﹤0.01% | 4792 |
|
|
2024
Q2 | $38K | Buy |
5,996
+5,145
| +605% | +$32.6K | ﹤0.01% | 3306 |
|
|
2024
Q1 | $6.98K | Sell |
851
-427
| -33% | -$3.5K | ﹤0.01% | 4284 |
|
|
2023
Q4 | $10.7K | Sell |
1,278
-6,004
| -82% | -$50.1K | ﹤0.01% | 4216 |
|
|
2023
Q3 | $93.9K | Buy |
7,282
+6,739
| +1,241% | +$86.9K | ﹤0.01% | 2026 |
|
|
2023
Q2 | $8.67K | Buy |
543
+293
| +117% | +$4.68K | ﹤0.01% | 4365 |
|
|
2023
Q1 | $3K | Sell |
250
-1,109
| -82% | -$13.3K | ﹤0.01% | 5220 |
|
|
2022
Q4 | $10K | Sell |
1,359
-2,693
| -66% | -$19.8K | ﹤0.01% | 4041 |
|
|
2022
Q3 | $29K | Buy |
4,052
+2,773
| +217% | +$19.8K | ﹤0.01% | 3629 |
|
|
2022
Q2 | $14K | Sell |
1,279
-471
| -27% | -$5.16K | ﹤0.01% | 4153 |
|
|
2022
Q1 | $13K | Buy |
+1,750
| New | +$13K | ﹤0.01% | 3990 |
|